Abstract:Objective: Drug-eluting stents have been used to markedly decrease in-stent restenosis in 6 months, but they are noticed due to the late thrombogenicity. The purpose of the present study was to evaluate the biocompatibility of Tetramethylpyrazine-eluting stents by investigating the intimal response and thrombogenicity in normal porcine coronary arteries by quantitative coronary angiography (QCA), intravascular ultrasound (IVUS) and histomorphometry.Methods: Bare metal stents (BMS) were uniformly spray-coated with Tetramethylpyrazine (TMP 200 mu g) and prepared for TMP-eluting stents (TES). Fourteen coronary arteries in 14 pigs underwent stent implantation. Seven TES were implanted in 7 pigs and 7 BMS in other 7 pigs. The stents were deployed with a stent-to-artery ratio of 1.1-1.2/1.0 in order to induce vascular wall injury. QCA and IVUS were performed before and immediately after the implantations and at 28 days (end time point). The analysis on blood cell count, biochemical parameters, status of behavior of pigs were evaluated before the implantation and at the time of I and 28 days. Stented-coronary arteries, stented-coronary arteries related ventricular wall, lung, liver and kidney were harvested after euthanasia of animals at the endpoint. Histopathology and histomorphometry had been done to assess the local toxicity of TES to these organs.Results: All the stents were successfully implanted, however, 4 pigs died of cardiac tamponade or anesthesia. No bone marrow depression and hemolysis was seen. No damage to the function and metabolism of liver and kidney was discovered. No thrombosis was found in control and test groups. Few inflammatory cells were found in the stented-coronary artery walls at each endpoint in both groups. No damage to stented-coronary arteries related ventricular wall, lung, liver and kidney was detected due to TES implantation. Compared with the control group, the neointimal area was significantly reduced in the TES group (60.2 +/- 23.5% vs 10.0 +/- 2.1%, P = 0.01) by IVUS analysis, but the lumen area in the TES group was increased (4.34 +/- 0.93 mm(2) vs 1.29 +/- 1.02 mm(2), p = 0.011), the neointimal area was reduced markedly (1.51 +/- 0.45 mm(2) vs 4.60 +/- 1.39 mm(2), P = 0.004).Conclusions: The biocompatibility of TES in porcine model at 28 days seems to be good and acceptable. Biocompatibility can be evaluated by IVUS and histopathology in a porcine restenosis model. (c) 2007 Elsevier Masson SAS. All rights reserved.

The efficacy of tetramethylpyrazine-eluting stents on inhibiting neointima formation in porcine coronary arteries]

Tetramethylpyrazine-Eluting Stents Prevented In-Stent Restenosis in a Porcine Model

Biocompatibility of Tetramethylpyrazine-Eluting Stents in Normal Porcine Coronary Arteries.

The Experimental Study of Tetramethylpyrazine-Eluting Stents on Preventing In-stent Intima Hyperplasia

Experimental Study of Preventive Effect of Tetramethylpyrazine-Eluting Stents on In-Stent Restenosis

Proliferation and Apoptosis of Smooth Muscle Cells after Implantation of Tetramethylpyrazine-Eluting Stents in the Porcine Coronary Artery

Effects of Tetramethylpyrazine-Eluting Stent on Neointimal Hyperplasia after Renal Artery Stenting

Evaluation of a novel polymer-free sirolimus-eluting stent in a porcine model

A novel stent coated with antibodies to endoglin inhibits neointimal formation of porcine coronary arteries.

Paclitaxel-eluting Stent Inhibits Restenosis in Peripheral Artery in a Swine Model of Diabetes: an Experiment Study

Polymer-free Dual Drug-Eluting Stents Evaluated in a Porcine Model

Prevention of Neointimal Formation after Angioplasty Using Tetramethylpyrazine-Coated Balloon Catheters in a Rabbit Iliac Artery Model.

Long-Term Effects of Novel Biodegradable, Polymer-Coated, Sirolimus-Eluting Stents on Neointimal Formation in A Porcine Coronary Model

Nanoporous Creg-Eluting Stent Attenuates In-Stent Neointimal Formation In Porcine Coronary Arteries

Evaluation of a Novel Paclitaxel-Eluting Stent with a Bioabsorbable Polymeric Surface Coating in the Porcine Artery Injury Model

Study on the effect of the stent coated with endothelial progenitor cells CD34 antibody on the porcine coronary restenosis

AS-115: Short-Term Effect of Tetramethylpyrazine-Eluting Stents on Neointimal Hyperplasia in Renal Arteries

Comparative preclinical evaluation of a polymer-free sirolimus-eluting stent in porcine coronary arteries

The Experimental Study in a Novel Targeting Sirolimus-Eluting Stents With Biodegradable Polymer for Preventing In-Stent Stenosis in Porcine Model

Preventive effect of a novel dexamethasone-heparin coated stent on restenosis in a porcine artery injury model

Efficacy and Safety of a Polytetrafluoroethylene Membrane Wrapped a Single Layer of Sirolimus-Eluting Stent in a Porcine Coronary Perforation Model